(PharmaNewsWire.Com, December 15, 2017 ) The Market Research Future provides detailed analysis of “Global 3D Bioprinting Market Research Report – forecast till 2023” by type, by indication and by end user. Worldwide 3D bio-printing Market is expected to grow at an approximate CAGR of 25% during the forecast period.
3D bio-printing involves the identification of the key architectural and compositional elements of a target tissue, and then creating a design that can be utilized by a bio-printer so as to generate that tissue in a laboratory environment. The technique is driving innovation in many areas of medicine, engineering, education, and others. 3D bio-printing is being applied to regenerative medicine to address the need for tissues and organs suitable for transplantation, which is driving the market growth along with the increasing healthcare expenditure. According to the U.S. Department of Health and Human Services, a total of 33,611 organ transplants were performed in 2016. Moreover, it was estimated that the 20 people die each day waiting for a transplant. Such trends in the organ transplantation demands can be easily satisfied by the application of the 3D bio-printing technology with several advantages of the biocompatibility and customisations. Additionally, technological advancements followed by the increasing investment in the pharmaceutical and biotechnology industries fuel the market growth. According to the International Trade Administration, the total turnover for the biotechnology sector in Germany reached from USD 3,280 million in 2015 to USD 3,410 million in 2016. Moreover, it was estimated that in 2016, R&D expenditure for biotech sector was about USD 1,040 million. Technical challenges related to the sensitivities of living cells and the construction of tissues, lack of skilled labours and awareness may restrain the market growth during the forecast period.
Top Key players for global 3D bio-printing market Are ORGANOVO HOLDINGS, INC. (U.S.), CELLINK AB (Sweden), Bio3D Technologies (Singapore), Aspect Biosystems Ltd. (Canada), Stratasys Ltd. (U.S.), Materialise (U.S.), FATHOM (U.S.), Allevi (U.S.), ENVISIONTEC, INC. (Germany), Nano3D Biosciences, Inc.(U.S.), Cyfuse Biomedical K.K. (Tokyo), 3Dynamic Systems Ltd. (U.K), REGENHU (Switzerland), Poietis (France), and others are some of the key players for the global 3D bio-printing market.
Segmentation: The global 3D bio-printing market is segmented on the basis of technology, material, application, and end users.
On the basis of the technology, the market is segmented into electron beam melting, laser beam melting, droplet disposition, syringe extrusion, magnetic levitation, and others. The laser beam melting segment is sub segmented into photo polymerization, stereo lithography, two-photon polymerization, and others. The droplet disposition segment is sub segmented into inkjet printing, fused disposition methods, multi-phase jet solidification, and others.
On the basis of the material, the market is segmented into cells, hydrogels, extracellular matrices, fibrinogen, alginate, and others.
On the basis of the application, the market is segmented into clinical, research, and others. The clinical segment is sub segmented into tissue transplantation, bone grafts, vascular grafts, wound care, and others. The wound care segment, by application, is further segmented into acute wounds, chronic wounds, hernia repair, and others. The research segment is sub-segmented into regenerative medicine, personalized healthcare, 3D cell culture, and others.
On the basis of the end users, the market is segmented into pharmaceutical & biotechnology companies, research organization, academic institutes, and others.
Regional Analysis: The Americas dominates the global 3D bio-printing market owing to a well-developed healthcare sector and huge patient population for organ transplantation drives the market growth within the region. Moreover, increasing healthcare expenditure and growing biotech sector boosts the market growth. Additionally, the presence of global players like ORGANOVO HOLDINGS, INC. and Stratasys Ltd. others within the region fuels the market growth during the forecast period.
Europe is the second largest 3D bio-printing market owing to the high healthcare expenditures and increasing government support for research & development. Moreover, the presence of the developed economies like Germany, U.K and France within the region fuels the market growth during the forecast period.
Asia Pacific is the fastest growing region in global market due to the presence of a huge patient population and continuously developing economies like India and China which have a growing healthcare industry. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector is one of the fastest growing industries and is expected to advance at a CAGR of 22.87% during 2015-2020 and reach USD280 billion by 2020.
On the other hand, the Middle East & Africa holds the least share in the global 3D bio-printing market due to presence of poor economies in the African region. A majority of the Middle East & Africa market is held by the Middle East due to the presence of developed economies like Kuwait, Saudi Arabia, Dubai and Qatar.
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
